Intradetrusor injections of onabotulinum toxin A (Botox ®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study

ConclusionsIntradetrusor injections of abobotulinum toxin 750 U for NDO provided better outcomes than injections of onabotulinum toxin 200 U. Success rates of abobotulinum toxin 750 U and onabotulinum toxin 300 U were similar but interval between injections tended to be longer with onabotulinum toxin 300 U. Neurourol. Urodynam. © 2016 Wiley Periodicals, Inc.

Source: Neurourology and Urodynamics - March 30, 2016 Category: Urology & Nephrology Authors: Benoit Peyronnet, Evelyne Castel ‐Lacanal, Mathieu Roumiguie, Lucie Even, Philippe Marque, Michel Soulié, Pascal Rischmann, Xavier Game Tags: Original Clinical Article Source Type: research